85 related articles for article (PubMed ID: 445512)
1. Failure of carnitine to prevent adriamycin cardiomyopathy.
Goldsmith MA; Suzuki Y; Ohnuma T; Holland JF
Cancer Treat Rep; 1979 Apr; 63(4):558-60. PubMed ID: 445512
[No Abstract] [Full Text] [Related]
2. Effects of L-carnitine on adriamycin-induced cardiomyopathy in rabbit.
Paterna S; Furitano G; Scaffidi L; Barbarino C; Campisi D; Parisi G; Carreca I
Int J Tissue React; 1984; 6(1):91-5. PubMed ID: 6715123
[TBL] [Abstract][Full Text] [Related]
3. Protection from adriamycin-induced cardiomyopathy in rats.
Shug AL
Z Kardiol; 1987; 76 Suppl 5():46-52. PubMed ID: 3433883
[TBL] [Abstract][Full Text] [Related]
4. Carnitine promotes heat shock protein synthesis in adriamycin-induced cardiomyopathy in a neonatal rat experimental model.
Strauss M; Anselmi G; Hermoso T; Tejero F
J Mol Cell Cardiol; 1998 Nov; 30(11):2319-25. PubMed ID: 9925368
[TBL] [Abstract][Full Text] [Related]
5. Prenylamine inhibition of adriamycin-induced cardiomyopathy in mice.
Milei J; Bolomo NJ; Marantz A
Medicina (B Aires); 1982; 42(4):409-14. PubMed ID: 15171023
[No Abstract] [Full Text] [Related]
6. [Myocardial disease caused by adriamycin. Experimental animal models and possible pharmacologic prevention].
Decorti G; Bartoli Klugmann F; Klugmann S
Minerva Med; 1982 May; 73(19):1275-82. PubMed ID: 7078806
[TBL] [Abstract][Full Text] [Related]
7. [Chronic toxicities of adriamycin (ADR) and their possible prevention by coenzyme Q10 and verapamil in rabbits--especially ADR induced cardiomyopathy (author's transl)].
Dohmae N; Sawada H; Tashima M; Uchino H; Matsuyama E; Konishi T
Nihon Gan Chiryo Gakkai Shi; 1979 Oct; 14(6):1009-28. PubMed ID: 541529
[No Abstract] [Full Text] [Related]
8. Abrogation of adriamycin-induced cardiotoxicity by selenium in rabbits.
Dimitrov NV; Hay MB; Siew S; Hudler DA; Charamella LJ; Ullrey DE
Am J Pathol; 1987 Feb; 126(2):376-83. PubMed ID: 3826299
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of HSP70 and ultrastructure of heart and liver tissues of rats treated with adriamycin: protective role of L-carnitine.
Strauss M; Porras N
Invest Clin; 2007 Mar; 48(1):33-43. PubMed ID: 17432542
[TBL] [Abstract][Full Text] [Related]
10. [Cardiomyopathy due to adriamycin: the possibility of its prevention. Monitoring by noninvasive technics].
Bianchi L; Bertocchi C; Felci U; Ferrario G; Giani P; Mariani L; Medolago G; Sarti E
Minerva Med; 1989 Mar; 80(3):215-26. PubMed ID: 2717043
[TBL] [Abstract][Full Text] [Related]
11. Verapamil in the prevention of adriamycin-induced cardiomyopathy.
Garbrecht M; Müllerleile U
Klin Wochenschr; 1986; 64 Suppl 7():132-4. PubMed ID: 3560773
[No Abstract] [Full Text] [Related]
12. Lack of the protective effect of solcoseryl on adriamycin-induced cardiomyopathy in rats.
Danysz A; Czarnecki A; Hinek A
Acta Pol Pharm; 1986; 43(5):504-9. PubMed ID: 3565049
[No Abstract] [Full Text] [Related]
13. [Prevention of adriamycin cardiomyopathies].
Cohen AM; Djaldetti M
Harefuah; 1983 May; 104(9):401-5. PubMed ID: 6674054
[No Abstract] [Full Text] [Related]
14. Doxorubicin (adriamycin) cardiomyopathy.
Saltiel E; McGuire W
West J Med; 1983 Sep; 139(3):332-41. PubMed ID: 6356608
[TBL] [Abstract][Full Text] [Related]
15. Adriamycin cardiomyopathy. Fatal outcome of general anaesthesia in a child with adriamycin cardiomyopathy.
McQuillan PJ; Morgan BA; Ramwell J
Anaesthesia; 1988 Apr; 43(4):301-4. PubMed ID: 3377152
[TBL] [Abstract][Full Text] [Related]
16. Carnitine prevention of adriamycin toxicity in mice.
Alberts DS; Peng YM; Moon TE; Bressler R
Biomedicine; 1978 Nov; 29(8):265-8. PubMed ID: 743560
[TBL] [Abstract][Full Text] [Related]
17. [Cardiomyopathy as a severe, reversible side effect of doxorubicin (adriamycin)].
Gerretsen M; Westerhof PW; Pinedo HM
Ned Tijdschr Geneeskd; 1978 Jul; 122(30):1096-8. PubMed ID: 683357
[No Abstract] [Full Text] [Related]
18. Doxorubicin-induced cardiomyopathy.
Muggia FM; Speyer JL
N Engl J Med; 1999 Feb; 340(8):654-5. PubMed ID: 10049088
[No Abstract] [Full Text] [Related]
19. Inorganic nitrate therapy improves Doxorubicin-induced cardiomyopathy a new window for an affordable cardiovascular therapy for everyone?
Daiber A; Gori T; Münzel T
J Am Coll Cardiol; 2011 May; 57(21):2190-3. PubMed ID: 21596235
[No Abstract] [Full Text] [Related]
20. Adriamycin-induced myocardial toxicity: new solutions for an old problem?
Outomuro D; Grana DR; Azzato F; Milei J
Int J Cardiol; 2007 Apr; 117(1):6-15. PubMed ID: 16863672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
